Two Sodastream investors sell shares at triple IPO price

Sodastream’s share price rose 3.6 percent on Friday to $73.35, giving a market cap of $1.46 billion, 237% above its IPO price.

By TALI TSIPORI / GLOBES
August 1, 2011 23:31
1 minute read.
The Jerusalem Post

bourse. (photo credit: Bloomberg)

Shareholders in Sodastream International Ltd. have decided on a second round of profit taking in the company and said good-bye to one of most successful investments in an Israeli company of the past decade, after selling $248.4 million in the company’s offer to sell and as the share price continued to climb.

Monitoring by Globes of Sodastream’s parties at interest found that two – Keswick Properties Ltd. and Kendray Properties Ltd. – liquidated their holdings within the past two weeks at an average price of $69.65 per share for a total of $71.9 million. The sale price was three times Sodastream’s IPO price last winter.

Be the first to know - Join our Facebook page.


Sodastream’s share price rose 3.6 percent on Friday to $73.35, giving a market cap of $1.46 billion, 237% above its IPO price.

Keswick Properties and Kendray Properties joined forces with Israeli privateequity fund Fortissimo Capital to acquire control of Sodastream just over four years ago at an investment of 10 million euros. Little is known about who is behind the two companies. Kendray Properties is registered in the tax haven of Gibraltar, and the name is derived from a village in Yorkshire.

Kendray Properties sold 4.1% of Sodastream for $57.5m., to complete an exit of $103.2m. on an investment of just a few million.

Keswick Properties is also registered in Gibraltar. It sold its remaining 1% of Sodastream for $14.4m., to complete an exit of $25.8m.

Altogether, parties at interest in Sodastream have sold $320.3m. worth of shares in the company, including in the offer to sell that accompanies the IPO. This amounts to half of sales by parties at interest in Israeli companies listed on Wall Street so far this year.


Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS

Israel Weather
  • 16 - 27
    Beer Sheva
    18 - 23
    Tel Aviv - Yafo
  • 16 - 23
    Jerusalem
    16 - 22
    Haifa
  • 23 - 36
    Elat
    17 - 28
    Tiberias